Safety Assessment of One-hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Tumors
Related studies linked through entity extraction aliases.
Ultrasonic Evaluation of Ocular Tissues
- Status
- UNKNOWN
- Phase
- N/A
Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE2
INNO-105 in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy
- Status
- COMPLETED
- Phase
- PHASE4
Rare Tumor Case Review
- Status
- TERMINATED
- Phase
- N/A
Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study Evaluating TTI-237 in Advanced Malignant Solid Tumors.
- Status
- TERMINATED
- Phase
- PHASE1
Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
- Status
- COMPLETED
- Phase
- NA
Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Novel Vaccine for the Treatment of MUC1-expressing Tumor Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Dasatinib in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2